We are delighted to announce that Professor John Turnidge will receive the International Society of Antimicrobial Chemotherapy’s highest and most prestigious award, the Hamao Umezawa Memorial Award (HUMA). The award, bestowed by the Microbial Chemistry Research Foundation of Japan in honour of the late Professor Umezawa, is given for outstanding contributions in the field of chemotherapy.
Professor Turnidge has had a distinguished and well-respected career in antimicrobial chemotherapy for more than forty years. Currently, Professor Turnidge is a Clinical Professor at the University of Adelaide as well as the Scientific Secretary for the European Committee on Antimicrobial Susceptibility Testing and the Senior Medical Consultant for the Australian Commission for Safety and Quality in Health Care’s (ACSQHC) Antimicrobial Usage and Resistance (AURA) project.
Professor Turnidge graduated in medicine from Sydney University in 1974 and subsequently trained in infectious diseases and microbiology at Flinders Medical Centre. He has a long-standing interest in antimicrobial prescribing and antimicrobial resistance, and has contributed nationally in these areas to government, international organisations and learned societies, including the Australian National Health and Medical Research Council (NHMRC), the Australian Therapeutic Guidelines-Antibiotic writing group, the World Health Organisation (WHO) and the US-based Clinical and Laboratory Standards Institute (CLSI).
Professor Turnidge has held numerous antimicrobial-related appointments throughout his career and these include: President of the Western Pacific Society for Chemotherapy; founding President of the Australian Society for Antimicrobials (ASA); Past President of the Australian Society for Microbiology (ASM); Member of the ACSQHC Health Care Associated Infections Antimicrobial Stewardship Advisory Committee; Member of the ACSQHC Antimicrobial Stewardship Committee; Chair of the Antibiotic Resistance Reference Group, NPS Medicine Wise; Chair of the National AST Committee (AUSNAC); Member of the ACSQHC Healthcare-Associated Infection Advisory Committee; and Member of the Australian Scientific and Technical Advisory Group National Antimicrobial Resistance Strategy.
Professor Turnidge has been an investigator on nine NHMRC research grants and his current research activities involve antimicrobial resistance surveillance and susceptibility testing, new antimicrobials, antimicrobial pharmacodynamics and antibiotic use.
During the 31st ICC – 4th GCCMID in Dubai, Professor Turnidge will present a keynote lecture on In Vitro Veritas - Susceptibility Testing in the 21st Century.